Market Overview

Jazz Pharmaceuticals Adds 2% on Q4 Earnings Results

Jazz Pharmaceuticals (NASDAQ: JAZZ) released its Q4 earnings results after the closing bell on Monday. The company reported EPS of $1.17, which compared to analysts' consensus estimates of $1.09.

Revenues for the quarter were $83.5 million versus consensus estimates of $80.84 million.

In Monday's after hours trading session, JAZZ shares are trading up a little better than 2% to $51.70.

Posted-In: Earnings News Guidance After-Hours Center Movers

 

Related Articles (JAZZ)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters